|
J Biol Chem, Vol. 273, Issue 12, 7052-7058, March 20, 1998
Enhancement of ATP Levels and Glucose Metabolism during an
Infection by Chlamydia
NMR STUDIES OF LIVING CELLS*
David M.
Ojcius ,
Hadassa
Degani§,
Joel
Mispelter¶, and
Alice
Dautry-Varsat
From the Unité de Biologie des Interactions
Cellulaires, CNRS 1960, Institut Pasteur, Paris, France and the
¶ Institut Curie, INSERM U350, Orsay, France
 |
ABSTRACT |
The Chlamydia species
are obligate intracellular bacteria that proliferate only within the
infected cell. Since the extracellular bacteria are metabolically
inert and there are no cell-free systems for characterizing
Chlamydia metabolism, we studied metabolic changes related
to ATP synthesis and glycolysis in HeLa cells infected with
Chlamydia psittaci during the course of the 2-day infection
cycle using noninvasive 31P and 13C NMR
methods. We find that the infection stimulates ATP synthesis in the
infected cell, with a peak of ATP levels occurring midway through the
infection cycle, when most of the metabolically active bacteria are
proliferating. The infection also stimulates synthesis of glutamate
with a similar time course as for ATP. The stimulation is apparently
due to an enhancement in glucose consumption by the infected cell,
which also results in an increased rate of lactate production and
glutamate synthesis as well as higher glycogen accumulation during the
infection. Concurrently, infection leads to an increase in the
expression of the glucose transporter, GLUT-1, on HeLa cells, which may
account for the enhanced glucose consumption. The chlamydiae are thus
able to stimulate glucose transport in the host cell sufficiently to
compensate for the extra energy load on the cell represented by the
infection.
 |
INTRODUCTION |
Chlamydia species are causative agents of
conjunctivitis and pneumonia, and they are recognized as the leading
cause of bacterially acquired sexually transmitted infections. On
repeated exposure, the consequences can be blinding trachoma or
sequelae from sexually transmitted infection, such as epididymitis or
pelvic inflammatory diseases, ectopic pregnancy, or tubal infertility
(1, 2). Despite the clinical importance of these infections, the
biology and biochemistry of Chlamydia infection remains
poorly understood.
The chlamydiae are obligate intracellular bacteria that proliferate
only within the infected host cell. In line with its requirement for
host cell metabolites for survival, Chlamydia exists in two developmental states, elementary bodies
(EBs)1 and reticulate bodies
(RBs). EBs represent the metabolically inactive, infectious form of the
bacteria, and they are internalized into host cells within
membrane-bound vacuoles that avoid fusion with host-cell lysosomes (3).
Within 6-10 h after internalization, the EBs differentiate into the
metabolically active RBs. This transformation triggers DNA, RNA, and
protein synthesis in the RBs, which proliferate in the growing vacuole
and produce up to a thousand progeny. Lipids from the
trans-Golgi network are transported to this membrane (4),
and the bacteria contribute their own proteins to the inclusion
membrane (5). An intimate association thus exists between the bacteria
and the host, but the lack of molecular tools in the field has made
further characterization of the association difficult. After
approximately 2 days of infection, RBs differentiate back into EBs, and
a new infection cycle can begin.
Chlamydia trachomatis grows well in cytoplasts (enucleated
cells) (6), indicating that active host cell nuclear function is not
required for bacterial growth. In addition, bacteria grow in host cells
treated with certain protein synthesis inhibitors, implying that
de novo protein synthesis by the host cell is also not
required (7). Nonetheless, a cell-free system for Chlamydia has never been obtained (3), and host-free RBs have limited metabolic
activity (8). The metabolism of the bacteria must therefore be studied
in infected cells themselves.
We have addressed metabolic changes in the infected cell using a
non-invasive NMR technique that allowed us to measure the levels and
rates of production of a number of metabolites related to energy
metabolism, including ATP, glucose, lactate, and glutamate. We find a
marked enhancement in the levels of the energy metabolites that
correlates well with the infection cycle of Chlamydia.
Concomitantly with this enhancement, glucose consumption, lactate
production, glutamate synthesis via the tricarboxylic acid cycle, and
glucose incorporation into glycogen increase, apparently due to
increased surface expression of glucose transporters by the host cell.
The chlamydiae thus fulfill their energy requirements by increasing the
expression of host cell glucose transporters, which by itself could
account for the other changes that we observe in energy-metabolite levels.
 |
EXPERIMENTAL PROCEDURES |
Cells and Materials--
The Chlamydia species used
here, the guinea pig inclusion conjunctivitis serovar of
Chlamydia psittaci has been described elsewhere (9). HeLa
cells were maintained in a humidified incubator at 37 °C with 5%
CO2 in high glucose Dulbecco's modified Eagle's medium
(Life Technologies, Inc.) supplemented with 10% heat-inactivated fetal
calf serum, 2 mM L-glutamine, and 50 µg/ml
gentamicin. The rabbit polyclonal antibody against the carboxyl
terminus of GLUT-1 (AB1340) was from Chemicon (Euromedex, Strasbourg,
France), and the fluorescein isothiocyanate-labeled
anti-Chlamydia lipopolysaccharide monoclonal antibody (clone
C4) was from Argene (Varilhes, France). R-Phycoerythrin-conjugated goat anti-rabbit IgG was from
Molecular Probes (Eugene, OR). Uridine
5'-diphospho-N-acetylglucosamine, uridine
5'-diphosphoglucoronic acid, and uridine 5'-diphosphoglucose were from
Sigma.
Preparation of Chlamydiae--
The chlamydiae were grown in
infected HeLa cell monolayer cultures essentially as described (10).
Briefly, infected HeLa cells were cultured on 20 9-cm Petri culture
dishes and harvested at 48 h postinfection. The cells and
supernatant were combined and centrifuged for 60 min at 12,000 rpm in a
Sorvall type GSA rotor. The pellet was resuspended in ice-cold
sucrose/phosphate/glucose buffer (SPG), and the cells were sonicated on
ice for 30 s. The resulting suspension was centrifuged for 10 min
at 2,000 rpm in a Sorvall SS34 rotor to remove unbroken cells, and the
new supernatant was centrifuged again for 30 min at 15,000 rpm at
4 °C to collect the bacteria. The pellet was resuspended in ice-cold
SPG with a 21-gauge 2-ml syringe to dissociate aggregates, giving the
final suspension of EBs used in subsequent infection experiments. This suspension was aliquoted and stored at 80 °C until ready for use.
Cell Cultures on Beads--
HeLa cells cultivated in a standard
manner were trypsinized and seeded on 150-µm biosylon microspheres
(Nunc, Denmark) or 300-µm polyacrolein microspheres (11) in small,
sterile plastic vials (3 million cells per 0.5-ml beads in 4 ml of
standard growth medium described above). The vials were placed in the
incubator (37 °C, 5% CO2, humidified) and agitated
gently every 15 min for a duration of 3 h. The beads with cells
were then transferred to 9-cm bacteriological Petri dishes and
additional medium was added until 12 ml was reached. Medium was
replaced every 2 days. Before the NMR experiment, the beads were
collected (2- or 2.5-ml beads) and transferred to a sterile 10-mm NMR
tube. The tube was then placed in the NMR spectrometer and perfused
with oxygenated growth medium at 37 °C using a sterile perfusion
system described in detail elsewhere (12).
For NMR experiments using Chlamydia-infected cells, biosylon
beads preseeded 2 days before with HeLa cells were incubated with
C. psittaci at (0.5-ml beads/2 ml of medium) at a
multiplicity of infection (m.o.i.) of approximately 0.3, and left on an
agitator for 1 h before adding additional culture medium (12 to
0.5 ml beads). Two to 2.5 ml of infected HeLa cells on beads were
transferred to a sterile NMR tube, and perfusion and data acquisition
was performed as for the uninfected HeLa cells.
For cell growth studies, HeLa cells were grown and infected on beads as
for NMR experiments (m.o.i. = ~0.3). Infected and uninfected cells
were trypsinized at the indicated times and counted using the viability
trypan blue exclusion method and light microscopy. In a separate
experiment, uninfected cells and cells infected with an m.o.i. of
~1.0 were harvested and viable cells were identified by their ability
to exclude propidium iodide in a FACScan flow cytometer (Becton
Dickinson, San Jose, CA).
Electron Microscopy--
Cells cultured on agarose-polyacrolein
beads were infected with chlamydiae for 0, 24, or 45 h and were
fixed with 2.5% glutaraldehyde overnight at 4 °C. The fixed cells
were centrifuged twice for 20 min at 15,000 rpm in PBS, and the pellet
was transferred in 2 ml of cacodylate buffer (5 mM
CaCl2, 5 mM MgCl2, 0.2 M cacodylate, pH 7) into an Eppendorf tube. The tube was
centrifuged and the pellet was resuspended in 200 µl of 3% agar
(Difco) in cacodylate buffer at 45 °C. The warm agar was centrifuged
1 min at 15,000 rpm and then allowed to solidify at 4 °C. One ml of
1% OsO4 in cacodylate buffer was added to the agar, and
after leaving for 1 h at room temperature, the supernatant was
removed and the pellet was incubated in a 1% uranyl acetate (Merck)
solution in cacodylate buffer for another hour at room temperature. The
supernatant was removed, the pellet was rinsed with water and then
dehydrated by rinsing with increasing concentrations (25, 50, 75, and
100%) of acetone. The preparations were then embedded in Epon.
Ultra-thin sections (60 µm) were prepared on an Ultra Cut 2 Reichert
GUNG microtome and poststained with uranyl acetate and lead citrate for
examination on a Zeiss electron microscope at an accelerating voltage
of 50 kV.
NMR Spectroscopy and Data Analysis--
Approximately 2-2.5 ml
of beads with about 1-2 × 107 cells were introduced
to the NMR probe in each experiment and were perfused with 60-400 ml
of medium, depending on the length and conditions of the
experiment.
NMR recording was performed with a Unity 400 spectrometer (Varian). The
temperature in the probe was maintained constant at 37 °C (in the
sample). 31P spectra were recorded at 161 MHz using 45°
pulses, an acquisition time of 0.2 s, and a repetition time of
2 s without proton decoupling. Each spectrum consisted of 1800 transients accumulated in 60 min. The chemical shifts of the
31P signals were assigned in reference to -NTP at
10.03 ppm. Since the line widths of the signals did not alter
throughout the course of the experiment, changes in signal intensity
were directly proportional to changes in the concentrations of the
metabolite.
13C spectra were recorded at 100 MHz by applying 45°
pulses, with 1-s repetition time and composite pulse proton decoupling during acquisition of ~2 watt. During the relaxation delay, the decoupling power was reduced 60-fold. Each spectrum was acquired for 30 min (1800 transients). These spectra were used to follow the energetics
of the HeLa cells through glycolysis, as well as monitoring the rates
of glucose consumption and lactate production and incorporation of the
label into glycogen and glutamate. For these measurements, glucose-free
Dulbecco's modified Eagle's medium supplemented with 11.2 or 16.8 mM [1-13C]glucose (99% enriched, from
Cambridge Isotope Laboratories, Andover, MA) in 100-150 ml of
re-circulating medium was used. The 13C signal of
C1- -glucose (96.8 ppm) served as a reference for chemical shift
determination. The rate of glucose utilization was determined from the
decrease in the [1-(13C + 13C )]glucose
intensity and the rate of lactate synthesis was measured from the
increase in the [3-13C]lacetate signal at 21 ppm. The
rates of labeling of C-4 glutamate and C-1 glucose moieties in glycogen
were determined from the change in the corresponding signal intensities
(at 32.4 and 101.4 ppm, respectively).
Preparation of Cell Extracts for NMR
Spectroscopy--
Water-soluble metabolites from HeLa cells were
extracted as described previously (13). Briefly, cells were extracted
with methanol, chloroform, and water (1:1:1, v/v/v), and the contents of the chloroform and methanol/water phases were separated and recovered. 31P spectra of the water-soluble metabolites
were obtained with a Unity 500 spectrometer (Varian) at a temperature
of 25 °C. The spectra were recorded at 202 MHz using 45° pulses
and a repetition time of 2.9 s with proton decoupling.
Cytofluorimetry Measurement of GLUT-1 Expression--
Adherent
HeLa cells growing at 50% confluence on 75-cm2 tissue
culture flasks (Costar) were incubated with 2 ml of chlamydiae (m.o.i. = ~0.3) or PBS for 2 h, agitating gently every 15 min, after
which 10 ml of culture medium was added. After culture for 1 day, the
cells were detached with EDTA, resuspended in 10 ml of PBS, and
centrifuged at 1,200 rpm for 5 min. The supernatant was removed and the
pellet was fixed by resuspending in 1 ml of 3.7% paraformaldehyde and
neutralizing with 50 mM NH4Cl as described previously (14). Following two additional washes with PBS, the cells
were incubated in 100 µl with the fluorescein isothiocyanate-labeled anti-Chlamydia monoclonal antibody (1:100 dilution) and the
rabbit polyclonal anti-GLUT-1 antibody (1:100 dilution) in PBS
containing 0.05% saponin for 45 min at 4 °C. The cells were washed
and incubated with 100 µl of the phycoerythrin-conjugated goat
anti-rabbit IgG (10 µg/ml) in PBS, 0.05% saponin for another 30 min
at 4 °C. Finally, the cells were washed twice in PBS without
detergent, resuspended in 1 ml of PBS/bovine serum albumin, and
transferred into 12 × 75-mm Falcon® 2052 FACS tubes (Becton
Dickinson, San Jose, CA). Data from 10,000 HeLa cells were collected on
the FACScan flow cytometer with an argon-ion laser tuned to 488 nm, and
the mean fluorescence intensity was obtained from the recorded
data.
 |
RESULTS |
Growth and Infection of HeLa Cells on Beads--
Mammalian cells
growing on biosylon and polyacrolein microspheres have previously been
used for non-invasive NMR measurements (11), and C. trachomatis has likewise been used to infect McCoy cells and
HEC-1B cells growing on beads (15, 16). We therefore verified whether
C. psittaci could infect bead-bound HeLa cells under the
conditions of our NMR experiments. The density of uninfected HeLa cells
was first evaluated by low magnification light microscopy, which
revealed predominantly a monolayer of HeLa cells growing at near
confluence under the conditions used for NMR (Fig.
1A). Electron microscopy
showed that uninfected HeLa cells were bound to the beads (Fig.
1B). After a 45-h infection with chlamydiae, a large
inclusion containing bacteria at both the EB and RB developmental stages is readily apparent (Fig. 1C), while the host cell
still remains firmly attached to the bead.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 1.
Microscopic characterization of HeLa cells
growing on beads. A, a low magnification profile of
confluent cells on beads, visualized by conventional light microscopy.
B, electron micrographs of uninfected cells; and
C, cells infected with C. psittaci for 45 h,
showing the beads (b), host cell nucleus (n), and
extracellular space (e). The arrowhead points to
a typical C. psittaci EB, and the arrow points to
an RB. Scale bars, 100 µm (A), 2 µm
(B), and 2 µm (C).
|
|
Effects of Chlamydia Infection on HeLa Cell Growth--
The NMR
signal for most of the metabolites measured below is derived only from
living HeLa cells, which can retain these metabolites; dead cells are
spectroscopically silent since the metabolites leaking from dead cells
are diluted in the extracellular perfusion medium. To assess the
viability and growth rate of cells on beads, we therefore studied the
growth curves for HeLa cells growing on beads that have been infected
with C. psittaci or incubated with control growth medium.
The cell number on beads was also counted in parallel to the NMR
experiments. An average of the growth curves for several NMR
experiments (n = 4 for infected cells,
n = 5 for control uninfected cells) is shown in Fig.
2, which indicates that infection at the
m.o.i. used here (~0.3) may have a slight effect on the number of
living cells. In a separate experiment, viability was also measured
using the propidium iodide exclusion assay by cytofluorimetry, using an
m.o.i. of ~1.0. Under these conditions, about one-third of the cells
were dead after a 2-day infection (not shown), suggesting that the
small effect seen in Fig. 2 may be significant.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Growth curve of HeLa cells on beads.
Uninfected cells ( ) or Chlamydia-infected cells ( )
growing on beads were harvested at different times and living cells
were counted, as described under "Experimental Procedures."
|
|
31P NMR Spectra of HeLa Cells--
Uninfected HeLa
cells or HeLa cells infected with C. psittaci were
transferred to a sterile NMR tube, and the tube was placed in the NMR
spectrometer and perfused at 37 °C with oxygenated growth medium for
periods up to 3 days. Sequential 31P spectra were acquired
continuously and signal-averaged every hour. A full spectrum of
uninfected HeLa cells on beads is shown in Fig.
3A. The most prominent peaks
are due to phosphocholine, inorganic phosphate (Pi), the
-phosphate of nucleoside triphosphate ( -NTP) (which also includes
-NDP), -NTP (which also includes -NDP), -NTP, and uridine
diphosphate sugars (UDPS). The assignment of the peaks was based on
known chemical shifts of phosphate metabolites from previous studies
(17, 18), and by spiking the NMR spectra of uninfected HeLa cell
extracts with uridine 5'-diphospho-N-acetylglucosamine, uridine 5'-diphosphoglucoronic acid, and uridine 5'-diphosphoglucose. A
typical extract spectrum is shown in Fig. 3B, which reveals the presence of the same metabolites as in Fig. 3A, but also
resolves the -NTP peak into -NTP and -ADP, and the -NTP
peak into -NTP and -NDP. Furthermore, the peak for UDPS is
resolved into UDP-N-acetylglucosamine, UDP-N-acetylgalactosamine, and UDP-glucoronic acid. However,
due to the invasive nature of the extraction technique and difficulties in quantitating the energy metabolites in extracts, this technique was
not used to study metabolism as a function of time during the
infection.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
31P spectra of HeLa cells.
A, spectrum of living cells growing on beads, acquired through
noninvasive NMR as described under "Experimental Procedures." The
main peaks correspond to phosphocholine (PC), extracellular
and intracellular inorganic phosphate (Pi),
-nucleoside triphosphate ( -NTP) plus -nucleoside diphosphate ( -NDP), -NTP plus -NDP, -NTP, and
UDPS. B, spectrum of water-insoluble extract, acquired with
conventional NMR as described under "Experimental Procedures."
Besides the peaks observed in living cells, peaks corresponding to
phosphocreatine (PCr), UDP-N-acetylglucosamine,
UPD-N-acetylgalactosamine, and UDP-glucoronic acid, as well
as -NDP and -NDP, become apparent. The two Pi peaks
in living cells collapse into one peak in the extracts.
|
|
Previous studies have determined that most of the nucleoside
triphosphates consist of ATP, which typically constitutes 60-70% of
the total NTP population (19, 20). In addition, the Pi peak, which is highly sensitive to the pH of the medium, is resolved in
the living cells into two peaks, corresponding to the extracellular pH
of the growth medium and the intracellular host cell pH (Fig. 3A). The peak due to the intracellular pH remains as a
single peak during the entire course of infection (not shown), implying that the pH of the vacuole containing chlamydiae, from early
internalization time points through the development of RB-laden
inclusions, does not differ significantly from the cytosolic pH, or
that the amount of Pi in the vacuole is too low to be
detected by this technique. This agrees with previous
immunofluorescence studies with pH-sensitive dyes showing that the pH
of the Chlamydia vacuole is approximately neutral during the
infection (21, 22).
Time Course of Phosphate Metabolite Levels during
Infection--
Changes in the levels of the different metabolites were
determined as a function of time by measuring the intensity of each peak in spectra recorded sequentially. As the line width of each peak
did not vary during the NMR recording, changes in peak intensity are
directly proportional to changes in the metabolite content. Fig.
4 shows the relative concentration for
-ATP and -ATP during 2 days, i.e. during one
Chlamydia-infection cycle. As mentioned above, the -ATP
peak includes a minor contribution from -ADP, but the -ATP peak
is due solely to -ATP. Compared with the levels in uninfected cells,
which increase monotonously due to continuing cell growth in the NMR
tube (see Fig. 2), there is an approximately 2-fold enhancement in the
levels of -ATP and -ATP in the infected cells. The signal for
these metabolites was normalized at time 0 for the number of cells at
the start of the NMR experiment. Since these values were not normalized
for later time points, the increase in -ATP and -ATP levels in
infected cells may in fact be underestimated if there are fewer living
cells among the infected cells than among the uninfected cells. With
the exception of phosphocholine (not shown), which should not be
affected appreciably by the energy requirements of the cell, all the
metabolites associated with energy consumption are enhanced by
infection.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Relative concentrations of representative
energy metabolites studied as a function of time by noninvasive NMR.
31P spectra were acquired in uninfected cells ( ) or
Chlamydia-infected cells ( ) as described under
"Experimental Procedures," and the peak intensities for
(A) -ATP plus -ADP and (B) -ATP were
plotted as a function of time.
|
|
For poorly understood reasons, the UPDS levels are not directly
proportional to the number of cells, but can also vary as a consequence
of minor changes in cell culture conditions (23). Thus, although we
observed changes in UDPS levels in infected cells that paralleled the
enhancement seen for ATP, we were unable to obtain reproducible changes
in UDPS levels in different uninfected cell samples (not shown).
13C NMR Spectra of Infected HeLa Cells--
To
investigate the possible origin of the ATP concentration enhancement,
we also measured changes in the metabolism of glucose. ATP is produced
when glucose is metabolized via glycolysis to lactate, and through the
tricarboxylic acid cycle, which is coupled to oxidative
phosphorylation. Besides glucose, the intermediates and end products
observed by us are glycogen, lactate, and glutamate.
For these experiments, HeLa cells were transferred into the NMR tube as
above, but the growth medium in the perfusion system was replaced with
a medium containing [1-13C]glucose at time 0. Fig.
5 displays the 13C NMR
spectra obtained immediately after adding the 13C-labeled
glucose (0 h, spectrum A) and 25 h later (spectrum B). At 0 h, the main metabolites observed are the - and -stereoisomers of
glucose, which are predominantly in the perfusion medium, with a small
broad peak around 30 ppm corresponding to the natural abundance of
13C, primarily intracellular membrane components. At
25 h, there is a significant decrease in the intensity of the
[1-13C]glucose peaks, with a concomitant increase of
other peaks, especially [3-13C]lactate, which is secreted
and accumulated in the perfusion medium, the intracellular
[4-13C]glutamate, and the [1-13C]glucose
residue in glycogen.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
13C spectra of HeLa cells.
Spectrum of living cells growing on beads, acquired immediately after
the addition of 13C-labeled glucose (0 h, spectrum
A) and 25 h later (spectrum B). At 0 h,
the main peaks correspond to the - and -isomers of glucose, between 90 and 100 ppm. At 30 h, there is a decrease in the
intensity of the [1-13C]glucose peaks, with a concomitant
increase of [3-13C]lactate and
[4-13C]glutamate, and the [1-13C]glucose in
glycogen. The insets show the intensity of the glucose (triangles) and lactate (circles) peaks as a
function of time in uninfected cells (left inset) and cells
that had been infected with C. psittaci at 0 h
(right inset).
|
|
The rates for glucose consumption and lactate production were
determined by plotting the intensities of the corresponding peaks and
measuring the slopes from 10 consecutive spectra (equivalent to 5 h) at a time. The insets of Fig. 5 display representative intensity versus time data for glucose disappearance and
lactate appearance, from which an acceleration in glucose consumption can be seen for the infected cell samples, since the glucose and lactate curves intersect sooner in the infected cell sample. Fig. 6 shows the slopes calculated for both
glucose consumption and lactate production. Invariably, the rate of
glucose consumption after 1 day of infection was at least twice as high
as in the uninfected controls.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Rates of (A) glucose consumption
and (B) lactate production in HeLa cells. The levels
of glucose and lactate were obtained from the 13C spectra
acquired on uninfected cells ( ) (n = 3) or
Chlamydia-infected cells ( ) (n = 2). The
rates were then determined for separate 5-h periods by calculating the
relative slopes at which the intensity of the glucose peaks decreased
and those of lactate increased. The slopes for the glucose intensities
were then multiplied by 1.
|
|
Glutamate and glycogen labeling could be followed in the same
experiment. As opposed to glucose and lactate, which are present predominantly in the growth medium, glutamate and glycogen are present
intracellularly. Similarly to the case for ATP, infection with C. psittaci leads to an enhancement in the rate of synthesis of
glutamate, whose levels are highest mid-way through the infection cycle
(Fig. 7A), and to glucose
incorporation into glycogen (Fig. 7B). In both infected and
control cells, glucose incorporation into glycogen occurs rapidly when
the perfusion medium with 13C-labeled glucose is
introduced, but in infected cells the accumulation of labeled glycogen
is about twice as high as in the uninfected controls (Fig.
7B).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Relative concentrations of (A)
glutamate and (B) glucose incorporated into glycogen
studied as a function of time by noninvasive NMR. 13C
spectra were acquired in uninfected cells ( ) or
Chlamydia-infected cells ( ) as described under
"Experimental Procedures."
|
|
GLUT-1 Expression in Infected HeLa Cells--
The rate of
glycolysis is limited by the concentration of the initial substrate,
glucose, which is in turn regulated by the presence of glucose
transporters on the cell surface (24-26). To determine if the enhanced
glucose consumption and lactate production, and consequently increased
ATP levels, may be due to Chlamydia-induced up-regulation of
glucose transport, we evaluated whether the expression of the
ubiquitous glucose transporter, GLUT-1 (27), changes during
infection.
HeLa cells were incubated with growth medium or infected with C. psittaci for 24 h, detached from the flasks, fixed with
paraformaldehyde, and permeabilized and incubated with monoclonal
antibody against Chlamydia and polyclonal antibodies against
GLUT-1. By cytofluorimetry, it was determined that the infection caused
up-regulation of GLUT-1 in the infected HeLa cell sample by a factor of
1.93 ± 0.30 (n = 4), consistent with the
enhancement of glucose consumption due to infection seen by NMR.
 |
DISCUSSION |
The large number of chlamydiae that proliferate within host cells
midway through infection raises the obvious question of whether the
host cells and/or bacteria can synthesize an additional amount of ATP
to compensate for the infection, or whether ATP levels in the host cell
decrease during the infection due to the extra energetic demands of the
bacteria. We find that not only is sufficient ATP synthesized in the
infected cells to maintain normal metabolic levels, but that the ATP
concentration increases above normal levels. A similar
Chlamydia-induced 2-3-fold enhancement was observed for
glycogen and glutamate, and their levels peaked halfway through the
infection cycle (24 h), when the metabolic activity of the chlamydiae
are also at their highest levels. The concentrations of the energy
metabolites then decreased to near-normal levels by 48 h, when
many of the RBs have begun to differentiate back to the metabolically
inactive EBs. These unexpected changes were paralleled by an increase
in the transport and consumption of glucose by the infected cell, which
may thus account for most if not all of the extra energy metabolites.
Consistent with this interpretation, it has been reported for both cell
and animal studies that the availability of glucose is the
rate-limiting step in glycolysis (24-26).
Recent data from the Chlamydia Genome Sequencing Project
(http://chlamydia-www.berkeley.edu/4231/) has revealed the presence of
several putative genes in C. trachomatis encoding proteins involved in energy metabolism, including enzymes in the glycolytic and
tricarboxylic acid cycle pathways. Assuming that the genes express
functional proteins, the chlamydiae could also contribute to the
enhanced ATP levels observed during the infection. As the NMR technique
cannot distinguish between ATP produced by the host cell and the
bacteria, the metabolic changes could be due to both host and bacteria.
Nonetheless, the overall ATP levels in the cell could not increase
unless higher glucose concentrations became available, and thus both
bacteria and host cells may benefit from the higher expression of host
cell glucose transporters.
In agreement with previous studies demonstrating an ATP-ADP exchange
activity in C. psittaci (8), the Chlamydia Genome Sequencing
Project has also revealed the existence of a Chlamydia ADP/ATP translocase, which is homologous to the ADP/ATP translocase of
another obligate intracellular bacterium, Rickettsia
prowazekii (28). Although host-free RBs have low, short-lived
metabolic activity, it was previously shown that isolated C. psittaci RBs, unlike the EBs, can in fact take up external ATP
through an ATP-ADP exchange mechanism (8). The Km
for transport was approximately 5 µM, well below the
eukaryotic ATP concentration of 1-5 mM. Thus, under the
conditions of our in vivo measurements by NMR, all of the
chlamydial transporters should have been functioning at
Vmax, their maximal rate. The requirement for
plentiful supplies of host-cell ATP was also demonstrated by studies
showing that the incorporation of exogenous glucose 6-phosphate,
pyruvate, isoleucine, and aspartate into chlamydial proteins (29) and
bacterial synthesis of lipids and maintenance of the intrabacterial
lysine pool (8, 29) also require exogenous ATP.
In contrast to our results, a recent study based on experiments with
acid-soluble extracts of host cells found that NTP levels decreased in
cells infected with chlamydiae (30). However, although we have used
soluble extracts to assign the peaks in our NMR spectra with known
standards, we have not attempted to use this invasive technique for
following metabolite concentrations during the infection because of the
inherent instability of the high-energy metabolites in the extracts and
difficulties in quantitating the relative changes in metabolite
concentrations in different extract preparations. Moreover, our
noninvasive NMR measurements on living cells revealed an increase in
the rate of glucose consumption midway through the infection cycle that
agreed well with the glucose concentration changes that had been
previously measured in the extracellular medium by standard chemical
assays, which showed that infection of cells with C. trachomatis or C. psittaci increases the rate of
consumption and catabolism of glucose (31-33).
The enhanced levels of energy metabolites in infected cells coincide
with an increase in glucose consumption, which is most likely due to a
Chlamydia-induced increase in the expression of glucose
transporters on the surface of the infected cell. We have in fact
observed that the expression of GLUT-1 increases by a factor of 2 in
HeLa cells infected with C. psittaci.
GLUTs are a family of facilitated glucose transporters whose members
have a high degree of sequence and structural homology among each other
(27). GLUT-1 has an ubiquitous tissue distribution and is responsible
for basal transport of glucose. Some transporters such as GLUT-4 are
distributed primarily in adipose tissue and muscle and are localized
almost exclusively in vesicles within the cell, while a substantial
proportion of GLUT-1 is found on the plasma membrane (34, 35). The
importance of GLUT-1 in energy metabolism in vivo has been
shown by overexpressing the transporter in the muscle of transgenic
mice, which led to enhanced glycolysis and increased levels of glycogen
in the muscle (24, 36).
Insulin causes translocation of GLUT-4 from the internal vesicular pool
to the plasma membrane, thus increasing cell surface levels of GLUT-4
by as much as 30-fold (27). However, GLUT-1 surface expression is
increased only 2-3-fold by insulin (37), similar to the up-regulation
induced by Chlamydia infection. Hence, the effects of
Chlamydia infection on GLUT-1 levels in HeLa cells resembles
the effects of insulin on GLUT-1 expression. It will now be worthwhile
determining if other microbial infections representing an energy drain
on the host also affect glucose transporter expression, and to
elucidate the molecular basis for the increased expression.
In conclusion, our studies indicate that chlamydiae compensate for the
extra energy load they represent on the infected cell by inducing an
increase in the expression of glucose transporters in the host cell,
which results in enhanced levels of high-energy metabolites in the
infected cell. Thus, the bacteria have succeeded in ensuring an
adequate supply of energy metabolites for themselves and for the
survival of the host cell, at least long enough for the bacteria to
undergo one complete infection cycle.
 |
ACKNOWLEDGEMENTS |
We are grateful to Véronique Colin and
Philippe Souque for excellent technical assistance, Muriel Delepierre
for help in the studies of cell extracts, Jean-Claude Bénichou
and Valérie Imberti for help obtaining electron micrographs, and
Richard Stephens (University of California, Berkeley) for communicating
his genome data before publication.
 |
FOOTNOTES |
*
This work was supported by the Institut Pasteur, CNRS,
Institut Curie (Orsay), and an EMBO fellowship (to H. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Institut Pasteur,
Biologie des Interactions Cellulaires, 25 rue du Dr. Roux, 75724 Paris
Cedex 15, France. Tel.: 33-1-40-61-30-64; Fax: 33-1-40-61-32-38; E-mail: ojcius{at}pasteur.fr.
§
Permanent address: Dept. of Biological Regulation, The Weizmann
Institute of Science, Rehovot, Israel.
1
The abbreviations used are: EB, elementary body;
RB, reticulate body; UDPS, uridine diphosphate sugars; PBS,
phosphate-buffered saline; m.o.i., multiplicity of infection.
 |
REFERENCES |
-
Paavonen, J.,
and Wolner-Hanssen, P.
(1989)
Hum. Reprod.
4,
111-124
-
Jackson, L. A.,
and Grayston, J. T.
(1996)
Curr. Opin. Infect. Dis.
9,
89-93
-
Moulder, J. W.
(1991)
Microbiol. Rev.
55,
143-190[Abstract/Free Full Text]
-
Hackstadt, T.,
Scidmore, M. A.,
and Rockey, D. D.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4877-4881[Abstract/Free Full Text]
-
Rockey, D. D.,
Heinzen, R. A.,
and Hackstadt, T.
(1995)
Mol. Microbiol.
15,
617-626[Medline]
[Order article via Infotrieve]
-
Perara, E.,
Yen, T. S.,
and Ganem, D.
(1990)
Infect. Immun.
58,
3816-3818[Abstract/Free Full Text]
-
Becker, Y.
(1978)
Microbiol. Rev.
42,
274-306[Free Full Text]
-
Hatch, T. P.,
Al-Hossainy, E.,
and Silverman, J. A.
(1982)
J. Bacteriol.
150,
662-670[Abstract/Free Full Text]
-
Bavoil, P. M.,
Hsia, R.-c.,
and Rank, R. G.
(1996)
Bull. Inst. Pasteur
94,
5-54 [CrossRef]
-
Batteiger, B. E.,
and Rank, R. G.
(1987)
Infect. Immun.
55,
1767-1773[Abstract/Free Full Text]
-
Neeman, M.,
Rushkin, E.,
Kadouri, A.,
and Degani, H.
(1988)
Magn. Reson. Med.
7,
236-242[Medline]
[Order article via Infotrieve]
-
Degani, H.,
Ronen, S. M.,
and Furman-Haran, E.
(1994)
in
NMR in Physiology and Biomedicine (Gillies, R. J., ed), pp. 329-351, Academic Press, San Diego
-
Tyagi, R. K.,
Azrad, A.,
Degani, H.,
and Salomon, Y.
(1996)
Magn. Reson. Med.
35,
194-200[Medline]
[Order article via Infotrieve]
-
Ojcius, D. M.,
Niedergang, F.,
Subtil, A.,
Hellio, R.,
and Dautry-Varsat, A.
(1996)
Res. Immunol.
147,
175-188[CrossRef][Medline]
[Order article via Infotrieve]
-
Raulston, J. E.
(1997)
Infect. Immun.
65,
4539-4547[Abstract]
-
Schachter, J.,
and Wyrick, P. B.
(1994)
Methods Enzymol.
236,
377-390[Medline]
[Order article via Infotrieve]
-
Evans, F. E.,
and Kaplan, N. O.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
4909-4913[Abstract/Free Full Text]
-
Navon, G.,
Navon, R.,
Shulman, R. G.,
Yamane, T.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
891-895[Abstract/Free Full Text]
-
Gallis, J.-L.,
Delmas-Beauvieux, M.-C.,
Biran, M.,
Rousse, N.,
Durand, T.,
and Canioni, P.
(1991)
NMR Biomed.
4,
279-285[Medline]
[Order article via Infotrieve]
-
Neeman, M.,
Eldar, H.,
Rushkin, E.,
and Degani, H.
(1990)
Biochim. Biophys. Acta
1052,
255-263[Medline]
[Order article via Infotrieve]
-
Heinzen, R. A.,
Scidmore, M. A.,
Rockey, D. D.,
Hackstadt, T.
(1996)
Infect. Immun.
64,
769-809[Abstract]
-
Schramm, N.,
Bagnell, C. R.,
and Wyrick, P. B.
(1996)
Infect. Immun.
64,
1208-1214[Abstract]
-
Shedd, S. F.,
Lutz, N. W.,
and Hull, W. E.
(1993)
NMR Biomed.
6,
254-263[Medline]
[Order article via Infotrieve]
-
Ren, J.-M.,
Marshall, B. A.,
Gulve, E. A.,
Gao, J.,
Johnson, D. W.,
Holloszy, J. O.,
Mueckler, M.
(1993)
J. Biol. Chem.
268,
16113-16115[Abstract/Free Full Text]
-
Bissell, M. J.
(1976)
J. Cell. Physiol.
89,
701-709[CrossRef][Medline]
[Order article via Infotrieve]
-
Dominguez, J. H.,
Song, B.,
Liu-Chen, S.,
Qulali, M.,
Howard, R.,
Lee, C. H.,
McAteer, J.
(1996)
J. Clin. Invest.
98,
395-404[Medline]
[Order article via Infotrieve]
-
James, D. E.,
Piper, R. C.,
and Slot, J. W.
(1993)
J. Cell Sci.
104,
607-612[Medline]
[Order article via Infotrieve]
-
Winkler, H. H.
(1990)
Annu. Rev. Microbiol.
44,
131-153[CrossRef][Medline]
[Order article via Infotrieve]
-
Weiss, E.,
and Wilson, N. N.
(1969)
J. Bacteriol.
97,
719-724[Abstract/Free Full Text]
-
Tipples, G.,
and McClarty, G.
(1993)
Mol. Microbiol.
8,
1105-1114[Medline]
[Order article via Infotrieve]
-
Gill, S. D.,
and Stewart, R. B.
(1970)
Can. J. Microbiol.
16,
997-1001[Medline]
[Order article via Infotrieve]
-
Moulder, J. W.
(1970)
J. Bacteriol.
104,
1189-1196[Abstract/Free Full Text]
-
Mavrov, I. I.,
Goncharenko, M. S.,
Shchegoleva, E. V.,
Chernobaeva, I. A.,
Pustovoitova, L. M.
(1991)
Mikrobiol. Zh. (Kiev)
53,
95-98
-
Hudson, A. W.,
Ruiz, M.,
and Birnbaum, M. J.
(1992)
J. Cell Biol.
116,
785-797[Abstract/Free Full Text]
-
Haney, P. M.,
Slot, J. W.,
Piper, R. C.,
James, D. E.,
Mueckler, M.
(1991)
J. Cell Biol.
114,
689-699[Abstract/Free Full Text]
-
Marshall, B. A.,
Ren, J.-M.,
Johnson, D. W.,
Gibbs, E. M.,
Lillquist, J. S.,
Soeller, W. C.,
Holloszy, J. O.,
Mueckler, M.
(1993)
J. Biol. Chem.
268,
18442-18445[Abstract/Free Full Text]
-
Piper, R. C.,
Hess, L. J.,
and James, D. E.
(1991)
Am. J. Physiol.
260,
C570-C580[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Rodenburg, I. M. J. Bovee-Oudenhoven, E. Kramer, R. van der Meer, and J. Keijer
Gene expression response of the rat small intestine following oral Salmonella infection
Physiol Genomics,
July 18, 2007;
30(2):
123 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wang, F. Burczynski, J. Anderson, and G. Zhong
Effect of host fatty acid-binding protein and fatty acid uptake on growth of Chlamydia trachomatis L2
Microbiology,
June 1, 2007;
153(6):
1935 - 1939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Al-Younes, J. Gussmann, P. R. Braun, V. Brinkmann, and T. F. Meyer
Naturally occurring amino acids differentially influence the development of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
J. Med. Microbiol.,
July 1, 2006;
55(Pt 7):
879 - 886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yaraei, L. A. Campbell, X. Zhu, W. C. Liles, C.-c. Kuo, and M. E. Rosenfeld
Effect of Chlamydia pneumoniae on Cellular ATP Content in Mouse Macrophages: Role of Toll-Like Receptor 2
Infect. Immun.,
July 1, 2005;
73(7):
4323 - 4326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Su, G. McClarty, F. Dong, G. M. Hatch, Z. K. Pan, and G. Zhong
Activation of Raf/MEK/ERK/cPLA2 Signaling Pathway Is Essential for Chlamydial Acquisition of Host Glycerophospholipids
J. Biol. Chem.,
March 5, 2004;
279(10):
9409 - 9416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Greene, Y. Xiao, Y. Huang, G. McClarty, and G. Zhong
Chlamydia-Infected Cells Continue To Undergo Mitosis and Resist Induction of Apoptosis
Infect. Immun.,
January 1, 2004;
72(1):
451 - 460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. C. Gencay, M. Tamm, A. Glanville, A. P. Perruchoud, and M. Roth
Chlamydia pneumoniae Activates Epithelial Cell Proliferation via NF-{kappa}B and the Glucocorticoid Receptor
Infect. Immun.,
October 1, 2003;
71(10):
5814 - 5822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Stenner-Liewen, H. Liewen, J. M. Zapata, K. Pawlowski, A. Godzik, and J. C. Reed
CADD, a Chlamydia Protein That Interacts with Death Receptors
J. Biol. Chem.,
March 15, 2002;
277(12):
9633 - 9636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. GENCAY, J. J. RÜDIGER, M. TAMM, M. SOLÉR, A. P. PERRUCHOUD, and M. ROTH
Increased Frequency of Chlamydia pneumoniae Antibodies in Patients with Asthma
Am. J. Respir. Crit. Care Med.,
April 1, 2001;
163(5):
1097 - 1100.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Coutinho-Silva, J.-L. Perfettini, P. M. Persechini, A. Dautry-Varsat, and D. M. Ojcius
Modulation of P2Z/P2X7 receptor activity in macrophages infected with Chlamydia psittaci
Am J Physiol Cell Physiol,
January 1, 2001;
280(1):
C81 - C89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Bavoil, R.-c. Hsia, and D. M. Ojcius
Closing in on Chlamydia and its intracellular bag of tricks
Microbiology,
November 1, 2000;
146(11):
2723 - 2731.
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Rivenzon-Segal, E. Rushkin, S. Polak-Charcon, and H. Degani
Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells
Am J Physiol Endocrinol Metab,
September 1, 2000;
279(3):
E508 - E519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Perfettini, T. Darville, G. Gachelin, P. Souque, M. Huerre, A. Dautry-Varsat, and D. M. Ojcius
Effect of Chlamydia trachomatis Infection and Subsequent Tumor Necrosis Factor Alpha Secretion on Apoptosis in the Murine Genital Tract
Infect. Immun.,
April 1, 2000;
68(4):
2237 - 2244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Escalante-Ochoa, R. Ducatelle, G. Charlier, K. De Vos, and F. Haesebrouck
Significance of Host Cell Kinesin in the Development of Chlamydia psittaci
Infect. Immun.,
October 1, 1999;
67(10):
5441 - 5446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tjaden, H. H. Winkler, C. Schwöppe, M. Van Der Laan, T. Möhlmann, and H. E. Neuhaus
Two Nucleotide Transport Proteins in Chlamydia trachomatis, One for Net Nucleoside Triphosphate Uptake and the Other for Transport of Energy
J. Bacteriol.,
February 15, 1999;
181(4):
1196 - 1202.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. M. Ojcius, P. Souque, J.-L. Perfettini, and A. Dautry-Varsat
Apoptosis of Epithelial Cells and Macrophages Due to Infection with the Obligate Intracellular Pathogen Chlamydia psittaci
J. Immunol.,
October 15, 1998;
161(8):
4220 - 4226.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|